U.S. Tobacco Firm Cabbacis Secures Pod Patent for Low-Nicotine and Industrial Hemp Blends

Key points:

·New patent details: The new patent covers a vaporizer pod containing regular and low-nicotine regenerated tobacco and hemp (often referring to industrial hemp), which provides a more unique taste compared to similar products. The patent is valid until 2038. 

·Intellectual property layout: In addition to the existing patents, the relevant mixed formula products are now covered in more than 30 countries, including major tobacco markets worldwide. 

·Product positioning: The iBlend™ series harm reduction products (such as low-nicotine cigarettes with nicotine content approximately 95% lower than traditional cigarettes) aim to guide users to reduce smoking or switch to safer alternatives.

According to the Financial Times reported on July 17, Cabbacis is a US federally licensed tobacco product manufacturer, focusing on developing reduced-risk products under the brand iBlend™. The company announced that the United States Patent and Trademark Office has awarded it a patent related to oral electronic vaporizer pods.

【2Firsts News Flash】The US patent number 12,349,724 is valid until July 27, 2038, and includes 10 claims related to electronic vaporizer pods. These claims cover vaporizer pods that contain a mixture of at least 5 mg of regular nicotine regenerated tobacco and at least 5 mg of hemp (typically referring to industrial hemp), as well as separate mixtures of at least 5 mg of low nicotine regenerated tobacco and at least 5 mg of hemp. Regenerated tobacco is typically used in closed-system electronic vaporizer pods. Common examples of closed-system electronic vaporizers (also known as HNB products) in the commercial market include IQOS®, Ploom®, and glo®.

Compared to vaporizer brands that only contain regular nicotine tobacco (with no hemp), the evaporator pod covered by patent 724, which contains regular nicotine tobacco and hemp, will provide consumers with a pleasurable and unique sensory experience.

Cabbacis previously held two additional U.S. patents (patent numbers 10,777,091 and 10,973,255) for vaporizer pods containing tobacco and hemp, as well as multiple international vaporizer pod patents.

The company is currently developing a patented product - low-nicotine iBlend™ evaporator pods and low-nicotine iBlend™ cigarettes, designed to help e-cigarette users or traditional tobacco smokers reduce their intake or transition to less harmful tobacco and nicotine products. The nicotine content of iBlend™ low-nicotine cigarettes is approximately 95% lower than traditional cigarette brands. The products being developed by the company have obtained patents in several of the world's largest tobacco markets, including the United States, China, Europe, Brazil, and Japan.

Cabbacis CEO Joseph Pandolfino stated:

“We are pleased to announce this new evaporator pod patent, which further strengthens our already strong intellectual property position. This patent, combined with our existing patents, provides comprehensive coverage in over 30 countries for low-nicotine tobacco and hemp mixed products, as well as regular nicotine tobacco and hemp mixed products in evaporator products.”